Aminobisphosphonates reduce MMP9 expression and the number of macrophages in the tumor stroma and decrease MDSCs infiltration in bone marrow and peripheral blood by decreasing serum pro-MMP9 and VEGF (159). The gene discussed is MMP9; the disease is neoplasm.